These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 19286201

  • 1. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R, Roscigno M, Freschi M, Strada E, Petralia G, Pasta A, Matloob R, Sozzi F, Da Pozzo L, Colombo R, Guazzoni G, Doglioni C, Montorsi F, Rigatti P.
    J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
    [Abstract] [Full Text] [Related]

  • 2. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H.
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [Abstract] [Full Text] [Related]

  • 3. TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion.
    Han KR, Bui MH, Pantuck AJ, Freitas DG, Leibovich BC, Dorey FJ, Zisman A, Janzen NK, Mukouyama H, Figlin RA, Belldegrun AS.
    J Urol; 2003 Mar; 169(3):899-903; discussion 903-4. PubMed ID: 12576809
    [Abstract] [Full Text] [Related]

  • 4. Renal cell carcinoma invading the urinary collecting system: implications for staging.
    Uzzo RG, Cherullo E, Myles J, Novick AC.
    J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
    [Abstract] [Full Text] [Related]

  • 5. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM.
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [Abstract] [Full Text] [Related]

  • 6. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?
    Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Frank I, Kwon ED, Zincke H, Blute ML.
    J Urol; 2005 Mar; 173(3):918-21. PubMed ID: 15711327
    [Abstract] [Full Text] [Related]

  • 7. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a.
    Siemer S, Lehmann J, Loch A, Becker F, Stein U, Schneider G, Ziegler M, Stöckle M.
    J Urol; 2005 Jan; 173(1):33-7. PubMed ID: 15592020
    [Abstract] [Full Text] [Related]

  • 8. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
    Canfield SE, Kamat AM, Sánchez-Ortiz RF, Detry M, Swanson DA, Wood CG.
    J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
    [Abstract] [Full Text] [Related]

  • 9. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML, Itano NB, Cheville JC, Weaver AL, Lohse CM, Zincke H.
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [Abstract] [Full Text] [Related]

  • 10. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.
    Sorbellini M, Kattan MW, Snyder ME, Reuter V, Motzer R, Goetzl M, McKiernan J, Russo P.
    J Urol; 2005 Jan; 173(1):48-51. PubMed ID: 15592023
    [Abstract] [Full Text] [Related]

  • 11. Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma.
    Jeong IG, Jeong CW, Hong SK, Kwak C, Lee E, Lee SE.
    Urology; 2006 Apr; 67(4):709-12. PubMed ID: 16566981
    [Abstract] [Full Text] [Related]

  • 12. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
    Carini M, Minervini A, Lapini A, Masieri L, Serni S.
    J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
    [Abstract] [Full Text] [Related]

  • 13. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC, Cheville JC, Lohse CM, Zincke H, Frank I, Kwon ED, Merchan JR, Blute ML.
    J Urol; 2005 Nov; 174(5):1759-63; discussion 1763. PubMed ID: 16217278
    [Abstract] [Full Text] [Related]

  • 14. Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?
    Leibovich BC, Cheville JC, Lohse CM, Zincke H, Kwon ED, Frank I, Thompson RH, Blute ML.
    J Urol; 2005 Mar; 173(3):716-9. PubMed ID: 15711250
    [Abstract] [Full Text] [Related]

  • 15. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma.
    Van Poppel H, Vandendriessche H, Boel K, Mertens V, Goethuys H, Haustermans K, Van Damme B, Baert L.
    J Urol; 1997 Jul; 158(1):45-9. PubMed ID: 9186320
    [Abstract] [Full Text] [Related]

  • 16. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
    Ishimura T, Sakai I, Hara I, Eto H, Miyake H.
    Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540
    [Abstract] [Full Text] [Related]

  • 17. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC, Zincke H, Lohse CM, Sebo TJ, Riehle D, Weaver AL, Blute ML.
    Cancer; 2002 Apr 15; 94(8):2180-4. PubMed ID: 12001115
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up.
    Lang H, Lindner V, Letourneux H, Martin M, Saussine C, Jacqmin D.
    Eur Urol; 2004 Sep 15; 46(3):331-5. PubMed ID: 15306103
    [Abstract] [Full Text] [Related]

  • 19. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
    Naitoh J, Kaplan A, Dorey F, Figlin R, Belldegrun A.
    J Urol; 1999 Jul 15; 162(1):46-50. PubMed ID: 10379737
    [Abstract] [Full Text] [Related]

  • 20. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.
    Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H.
    J Urol; 2004 Aug 15; 172(2):465-9. PubMed ID: 15247704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.